The small molecule S63845 (Servier Laboratories, Suresnes, France and Novartis, Basel, Switzerland) [174] has been shown to bind with high affinity to the BH3-binding groove of MCL-1, resulting in apoptosis of MCL-1–dependent multiple myeloma, leukemia, and lymphoma cells [174]. This evidence concerns the gene MCL1 and lymphoma.